C12N 2720/12334
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2720/12334 (Use of virus or viral component as vaccine) appears on 140 US grants and 165 published applications in this corpus.
Search patents in C12N- Granted patents
- 140
- Published applications
- 165
- Assignees
- 118
- Inventors
- 365
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 7 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 5 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 8 |
| 2003 | 5 | 7 |
| 2004 | 2 | 6 |
| 2005 | 1 | 6 |
| 2006 | 3 | 3 |
| 2007 | 2 | 1 |
| 2008 | 3 | 10 |
| 2009 | 3 | 5 |
| 2010 | 3 | 10 |
| 2011 | 2 | 7 |
| 2012 | 5 | 6 |
| 2013 | 4 | 9 |
| 2014 | 5 | 5 |
| 2015 | 2 | 6 |
| 2016 | 4 | 6 |
| 2017 | 7 | 9 |
| 2018 | 9 | 10 |
| 2019 | 9 | 11 |
| 2020 | 9 | 5 |
| 2021 | 4 | 10 |
| 2022 | 7 | 9 |
| 2023 | 4 | 4 |
| 2024 | 4 | 5 |
| 2025 | 4 | 4 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Combined norovirus and rotavirus vaccine composition and methods of preparation31 Mar 2026US 12,589,144 B2Bharat Biotech International Limited
- Adjuvant compositions13 Jan 2026US 12,521,433 B2Zoetis Services LLC
- Rotavirus vaccines3 Jun 2025US 12,318,444 B2Cure Vac SE
- Porcine rotavirus13 May 2025US 12,297,459 B2Intervet Inc.
- Thermostable quick-dissolving thin film4 Feb 2025US 12,214,087 B2
- Vp4-based trivalent pseudovirus nanoparticle vaccine for rotavirus and methods of using same9 Jul 2026US 2026/0191949 A1Children's Hospital Medical Center
- Rotavirus b virus-like-particle compostions and antibody assays11 Jun 2026US 2026/0158131 A1University of Kentucky Research Foundation
- Rotavirus vaccines1 Jan 2026US 2026/0000749 A1CureVac AG
- Rotavirus vaccines4 Sep 2025US 2025/0276053 A1VST LLC dba Medgene
- Recombinant rotavirus expressing exogenous protein and uses thereof21 Aug 2025US 2025/0263443 A1The Trustees of Indiana University
Most cited
By later US patents
- Oral vaccines118US 4,920,209 AAmerican Home Products Corporation · 1990
- Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system81US 5,891,676 ABaylor College of Medicine · 1999
- Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system78US 5,843,733 ABaylor College of Medicine · 1998
- DNA vaccines against rotavirus infections47US 6,165,993 AUniversity of Massachusetts Medical Center · 2000
- DNA vaccines against rotavirus infections45US 5,620,896 AUniversity of Massachusetts Medical Center · 1997